期刊文献+

Impact of obesity treatment on gastroesophageal refluxdisease 被引量:9

Impact of obesity treatment on gastroesophageal reflux disease
下载PDF
导出
摘要 Gastroesophageal reflux disease(GERD) is a frequently encountered disorder. Obesity is an important risk factor for GERD, and there are several pathophysiologic mechanisms linking the two conditions. For obese patients with GERD, much of the treatment effort is focused on weight loss and its consistent benefit to symptoms, while there is a relative lack of evidence regarding outcomes after novel or even standard medical therapy is offered to this population. Physicians are hesitant to recommend operative anti-reflux therapy to obese patients due to the potentially higher risks and decreased efficacy, and these patients instead are often considered for bariatric surgery. Bariatric surgical approaches are broadening, and each technique has emerging evidence regarding its effect on both the risk and outcome of GERD. Furthermore, combined antireflux and bariatric options are now being offered to obese patients with GERD. However, currently Rouxen-Y gastric bypass remains the most effective surgical treatment option in this population, due to its consistent benefits in both weight loss and GERD itself. This article aims to review the impact of both conservative and aggressive approaches of obesity treatment on GERD. Gastroesophageal reflux disease(GERD) is a frequently encountered disorder. Obesity is an important risk factor for GERD, and there are several pathophysiologic mechanisms linking the two conditions. For obese patients with GERD, much of the treatment effort is focused on weight loss and its consistent benefit to symptoms, while there is a relative lack of evidence regarding outcomes after novel or even standard medical therapy is offered to this population. Physicians are hesitant to recommend operative anti-reflux therapy to obese patients due to the potentially higher risks and decreased efficacy, and these patients instead are often considered for bariatric surgery. Bariatric surgical approaches are broadening, and each technique has emerging evidence regarding its effect on both the risk and outcome of GERD. Furthermore, combined antireflux and bariatric options are now being offered to obese patients with GERD. However, currently Rouxen-Y gastric bypass remains the most effective surgical treatment option in this population, due to its consistent benefits in both weight loss and GERD itself. This article aims to review the impact of both conservative and aggressive approaches of obesity treatment on GERD.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第4期1627-1638,共12页 世界胃肠病学杂志(英文版)
关键词 Obesity GASTROESOPHAGEAL REFLUX disease FUNDOPLICATION Sleeve GASTRECTOMY GASTRIC BANDING GASTRIC bypass Obesity Gastroesophageal reflux disease Fundoplication Sleeve gastrectomy Gastric banding Gastric bypass
  • 相关文献

参考文献118

  • 1Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosisand management of gastroesophageal reflux disease. Am JGastroenterol 2013; 108: 308-328; quiz 329 [PMID: 23419381DOI: 10.1038/ajg.2012.444]. 被引量:1
  • 2Song JH, Chung SJ, Lee JH, Kim YH, Chang DK, Son HJ, KimJJ, Rhee JC, Rhee PL. Relationship between gastroesophagealreflux symptoms and dietary factors in Korea. J NeurogastroenterolMotil 2011; 17: 54-60 [PMID: 21369492 DOI: 10.5056/jnm.2011.17.1.54]. 被引量:1
  • 3Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA.Body-mass index and symptoms of gastroesophageal reflux inwomen. N Engl J Med 2006; 354: 2340-2348 [PMID: 16738270DOI: 10.1056/NEJMoa054391]. 被引量:1
  • 4Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatalhernia and esophagitis. Am J Gastroenterol 1999; 94: 2840-2844[PMID: 10520831 DOI: 10.1111/j.1572-0241.1999.01426.x]. 被引量:1
  • 5Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK,Kahrilas PJ. Obesity: a challenge to esophagogastric junctionintegrity. Gastroenterology 2006; 130: 639-649 [PMID: 16530504DOI: 10.1053/j.gastro.2005.12.016]. 被引量:1
  • 6Roman S, Pandolfino JE. Environmental - lifestyle related factors.Best Pract Res Clin Gastroenterol 2010; 24: 847-859 [PMID:21126698 DOI: 10.1016/j.bpg.2010.09.010]. 被引量:1
  • 7Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity isassociated with increased transient lower esophageal sphincterrelaxation. Gastroenterology 2007; 132: 883-889 [PMID:17324403 DOI: 10.1053/j.gastro.2006.12.032]. 被引量:1
  • 8Ter RB. Gender differences in gastroesophageal reflux disease. JGend Specif Med 2000; 3: 42-44 [PMID: 11253245]. 被引量:1
  • 9Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hrambulatory esophageal pH values. Influence of study center, pHelectrode, age, and gender. Dig Dis Sci 1992; 37: 849-856 [PMID:1587189 DOI: 10.1007/BF01300382]. 被引量:1
  • 10Close H, Mason JM, Wilson D, Hungin AP. Hormone replacementtherapy is associated with gastro-oesophageal reflux disease: aretrospective cohort study. BMC Gastroenterol 2012; 12: 56 [PMID:22642788 DOI: 10.1186/1471-230X-12-56]. 被引量:1

同被引文献47

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部